ValuEngine downgraded shares of SIGA Technologies (OTCMKTS:SIGA) from a hold rating to a sell rating in a research report released on Tuesday morning.
SIGA Technologies (SIGA) opened at $4.90 on Tuesday. SIGA Technologies has a 1 year low of $2.56 and a 1 year high of $5.24. The company has a debt-to-equity ratio of -0.22, a current ratio of 3.14 and a quick ratio of 2.91.
COPYRIGHT VIOLATION NOTICE: “SIGA Technologies (SIGA) Lowered to “Sell” at ValuEngine” was originally published by Chaffey Breeze and is the sole property of of Chaffey Breeze. If you are accessing this story on another website, it was illegally copied and republished in violation of United States & international trademark & copyright legislation. The correct version of this story can be accessed at https://www.chaffeybreeze.com/2017/12/06/siga-technologies-siga-lowered-to-sell-at-valuengine.html.
SIGA Technologies, Inc is engaged in the development and commercialization of solutions for various unmet medical needs and biothreats. The Company’s lead product is TPOXX, an orally administered antiviral drug that targets orthopoxviruses infections. TPOXX is a small-molecule drug delivered to the Strategic Stockpile under the Project BioShield Act of 2004 (Project BioShield).
Receive News & Ratings for SIGA Technologies Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SIGA Technologies Inc. and related companies with MarketBeat.com's FREE daily email newsletter.